Innova Captab Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹380Cr
- +19.5% YoY
- +8% QoQ
- Net profit
- ₹30Cr
- −14.3% YoY
- −3.2% QoQ
- Margin
- 14%
- −2 pp YoY
- −1 pp QoQ
Guidance rank: #12 of 87 in Pharmaceuticals & Biotechnology
See the sector's top 10 — free with your mobile number.
Innova Captab Ltd Q2 FY26 key numbers
- Revenue
- The Jammu facility is planned to ramp up over a 3-4 year horizon, targeting north of INR 1,400 crores revenue at 65-70% capacity utilization.
As stated in Innova Captab Ltd's Q2 FY26 earnings call transcript · published 6 Aug 2026. Reported figures, not investment advice.
The short version
Innova Captab targets 20%+ top-line growth over the next 3-4 years, aiming to double revenue as per past trends. Innova Captab aims to double its top line in the next 3 to 4 years, targeting a 20%+ annual growth trajectory.
From Innova Captab Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Innova Captab targets 20%+ top-line growth over the next 3-4 years, aiming to double revenue as per past trends.
- The Jammu facility is planned to ramp up over a 3-4 year horizon, targeting north of INR 1,400 crores revenue at 65-70% capacity utilization.
- Current Jammu revenue is around INR 120 crores for H1 FY26, targeting approximately INR 270-280 crores for full FY26, below the initial INR 400 crores estimate due to API price correction.
- CDMO business is witnessing 15% YoY growth in Q2 FY26, supported by expanding client base and product portfolio.
- Branded Generics segment shows strong growth at 31% YoY in Q2 FY26 and 43% in H1 FY26.
2 more points from Innova Captab Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Innova Captab Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Innova Captab invested approximately INR480 crores in the Jammu facility.
- The Jammu plant is expected to reach 65%-70% capacity utilization within 3-4 years.
- Peak revenue potential from Jammu is estimated at north of INR1,400 crores.
2 more points from Innova Captab Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Innova Captab Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Innova Captab has a strong order book, which is expected to support growth in the coming months.
- The company is optimistic about sustaining growth momentum due to this robust pipeline.
- Several prominent pharmaceutical companies have completed audits and reviews at the new Jammu facility, with business operations commenced with some and advanced discussions ongoing with others.
- This strong foundation is expected to enable scale-up in the near term.
2 more points from Innova Captab Ltd's call on order book
Create a free account to keep reading this call
Innova Captab Ltd — Quarterly revenue & net profit
Innova Captab Ltd Q2 FY26 results — key figures
| ₹ Cr | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 380 | 318 | +19.5% | 352 | +8% |
| Operating profit (EBITDA) | 52 | 50 | +4% | 52 | 0% |
| Operating margin | 14% | 16% | -2 pp | 15% | -1 pp |
| Profit before tax | 39 | 47 | -17% | 43 | -9.3% |
| Net profit (PAT) | 30 | 35 | -14.3% | 31 | -3.2% |
| EPS (₹) | 5.18 | 6.12 | -15.4% | 5.42 | -4.4% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹496 Cr, net profit ₹42 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Innova Captab's management said in earlier quarters
Others in Pharmaceuticals & Biotechnology this season
- Bajaj Healthcare (Q2 FY26)
For HYE (Half Year Ending) Sept 2025, Total Income reported is ₹299.28 crore. Key investor presentation takeaways from Bajaj Healthcare Ltd's Q2 FY26 investor p
- Infinium Pharma (Q2 FY26)
Revenue from Operations for H1FY26: Rs 84.05 crore, a 1% YoY increase from Rs 82.98 crore in H1FY25 (Page 22). Key investor presentation takeaways from Infinium
- Wanbury (Q2 FY26)
Q2FY26 Revenue from Operations: ₹160.06 Crore . Key investor presentation takeaways from Wanbury Ltd's Q2 FY26 investor presentation — and how it ranks against
- Balaxi Pharma (Q2 FY26)
Revenue for Q2 FY26: ₹56.17 crore . Key investor presentation takeaways from Balaxi Pharma's Q2 FY26 investor presentation — and how it ranks against sector pee
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Innova Captab Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Innova Captab Ltd Q2 FY26 results?
Innova Captab targets 20%+ top-line growth over the next 3-4 years, aiming to double revenue as per past trends. Innova Captab aims to double its top line in the next 3 to 4 years, targeting a 20%+ annual growth trajectory.
What is Innova Captab Ltd share price analysis?
Innova Captab Ltd currently shows a neutral. The stock trades at a P/E of 38.5 with a market cap of ₹5,408 Cr. Investors should review the full earnings analysis for detailed insights.
Is Innova Captab Ltd planning capital expenditure?
Innova Captab invested approximately INR480 crores in the Jammu facility.
Keep Innova Captab Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
